Completed NA INTERVENTIONAL 2-arm NCT00583778

A Comparison of Levalbuterol Plus Ipratropium With Levalbuterol Alone in the Treatment of Acute Asthma Exacerbation

Sponsor: MetroHealth Medical Center

Conditions Asthma

Interventions ipratropium

Updated 8 times since 2017 Last updated: May 12, 2022 Started: Aug 31, 2004 Primary completion: Nov 30, 2008 Completion: Dec 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00583778, this NA trial focuses on Asthma and remains completed. Sponsored by MetroHealth Medical Center, it has been updated 8 times since 2004, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Sep 2023 — Jul 2024 [monthly]

Completed NA
Jun 2022 — Sep 2023 [monthly]

Completed NA
Jan 2021 — Jun 2022 [monthly]

Completed NA

▶ Show 3 earlier versions

Sep 2019 — Jan 2021 [monthly]

Completed NA
Jun 2018 — Sep 2019 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Aug 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

MetroHealth Medical Center
Sumitomo Pharma America, Inc.

Data source: MetroHealth Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cleveland, United States